PMVP Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 11:46):

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer...

Stats
Today's Volume	145 519
Average Volume	574 235
Market Cap	87.20M
EPS	$0 ( 2024-03-06 )
Next earnings date	( $-0.350 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.180
ATR14	$0.00500 (0.29%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-18	Jalota Deepika	Buy	225 095	Employee Stock Option (right to buy)
2024-01-18	Jalota Deepika	Buy	95 555	Common Stock
2024-01-18	Carulli Michael	Buy	204 630	Employee Stock Option (right to buy)
2024-01-18	Carulli Michael	Buy	82 220	Common Stock
2024-01-18	Mack David Henry	Buy	519 915	Employee Stock Option (right to buy)

INSIDER POWER
60.23
Last 97 transactions
Buy: 3 540 873 \| Sell: 1 925 887

Volume Correlation

Long: -0.08 (neutral)

Short: 0.00 (neutral)

Signal:(43.278) Neutral

PMV Pharmaceuticals, Inc. Correlation

10 Most Positive Correlations
FCBC	0.942
HOL	0.938
EVLO	0.937
LGMK	0.935
FIBK	0.935
EQBK	0.935
GRNA	0.933
BHTG	0.931
SLNG	0.928
LYEL	0.928

10 Most Negative Correlations
GVCI	-0.96
APTM	-0.958
SCRM	-0.956
DPCS	-0.956
CCTS	-0.955
ORIA	-0.954
TIOA	-0.954
XPAX	-0.953
ARRW	-0.951
FRONU	-0.951

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PMV Pharmaceuticals, Inc. Correlation - Currency/Commodity

0.20
( neutral )

0.27
( neutral )

0.00
( neutral )

-0.76
( moderate negative )

0.00
( neutral )

0.26
( neutral )

PMV Pharmaceuticals, Inc. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-1.26M (0.00 %)
EPS:	$-1.440

Q4	2023
Revenue:	$1.62M
Gross Profit:	$1.26M (77.81 %)
EPS:	$-0.310

Q3	2023
Revenue:	$0
Gross Profit:	$-358 000 (0.00 %)
EPS:	$-0.340

Q2	2023
Revenue:	$0
Gross Profit:	$-369 000 (0.00 %)
EPS:	$-0.380

Financial Reports:

No articles found.

PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.